Accenture Positioned as a Leader in Life Science Drug Safety Services By Leading Industry Research Firm

Mon Apr 8, 2013 8:30am EDT

* Reuters is not responsible for the content in this press release.

Report Cites Accenture`s Solid Customer Base with Top Pharma and Emerging Life
Sciences Companies And Strong Emphasis on IP Development as Key Leadership
NEW YORK--(Business Wire)--
Accenture (NYSE: ACN) has been positioned as a "Leader" in IDC Health Insights'
recently published report, "IDC MarketScape: Worldwide Life Sciences Drug Safety
Services 2013 Vendor Assessment." 1 The report contains a vendor assessment -
derived from both qualitative and quantitative metrics as well as end-user
feedback - of drug safety service providers in the life sciences industry
through the IDC MarketScape model. Click here for a link to the report. 

IDC Health Insights assessed 10 drug safety service providers for this report,
which is designed to evaluate the characteristics of each firm. In naming
Accenture as a leader, the report`s author, Alan S. Louie, PhD, Research
Director, Clinical Development Strategy and Technology, IDC Health Insights,
said: "Accenture`s market-leading revenue in the drug safety services space,
solid customer base with both top pharma and emerging life sciences companies,
and strong emphasis on IP development makes the company a formidable competitor
in drug safety." 

"We believe Accenture's positioning as a leader in this new report is
verification of the results we deliver every day to our life sciences` clients
who entrust us with drug safety services," said David Boath, senior managing
director and global lead of Accelerated R&D Services for Accenture`s Life
Sciences practice. "End-to-end pharmacovigilance is a critical component of our
integrated Accelerated R&D services, designed to deliver quality, compliance and
efficiency, which helps our clients to industrialize their operations, derive
insights and reduce costs, so they can focus on strategic decision making that
improves safety for patients around the world." 

The IDC MarketScape divides potential key strategy measures for success into two
primary categories: capabilities and strategies. IDC Health Insights
specifically noted in this report, "With its performance-based approach options
and significant dedication to innovate, it is clear that Accenture has a clear
vision and commitment to growth in this area." 

IDC Health Insights focuses on the following key criteria in defining excellence
in drug safety services:

* Service focus experience (i.e., BPO, IT services, or strategic consulting
* Breadth of service offerings (supporting BPO) 
* Diversity of resources and infrastructure supporting services delivery 
* Project experience in the life science Drug Safety Services outsourcing market

* Strength of project leaders and their teams 
* Quality of work and customer satisfaction

1IDC MarketScape: Worldwide Life Science Drug Safety Services 2013 Vendor
Assessment, doc #HI239221, February 2013. Click here to access the full report. 

About Accenture

Accenture is a global management consulting, technology services and outsourcing
company, with approximately 261,000 people serving clients in more than 120
countries. Combining unparalleled experience, comprehensive capabilities across
all industries and business functions, and extensive research on the world`s
most successful companies, Accenture collaborates with clients to help them
become high-performance businesses and governments. The company generated net
revenues of US$27.9 billion for the fiscal year ended Aug. 31, 2012. Its home
page is 

About IDC MarketScape

IDC MarketScape vendor analysis model is designed to provide an overview of the
competitive fitness of IT, telecommunications, or industry-specific suppliers in
a given market. The research methodology utilizes a rigorous scoring methodology
based on both qualitative and quantitative criteria that results in a single
graphical illustration of each vendor`s position within a given market. IDC
MarketScape provides a clear framework in which the product and service
offerings, capabilities and strategies, and current and future market success
factors of IT, telecommunications, or industry-specific vendors can be
meaningfully compared. The framework also provides technology buyers with a
transparent foundation to allow companies to independently compare the strengths
and weaknesses of current and prospective vendors.

Photos/Multimedia Gallery Available:

Cam Granstra, 312-693-5992

Copyright Business Wire 2013